NCT01488747

Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride

Bioavailability of Fish Oils: Emulsified vs. Capsular Triglyceride

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: USDA Grand Forks Human Nutrition Research Center · Federal
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this investigation is to determine the relative percentage and rate of incorporation of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total omega-3 (n-3) fatty acids after ingestion of 4 emulsified flavored triglyceride fish oil supplements versus an encapsulated triglyceride in defined plasma lipid pools. The primary endpoints to be evaluated include the fatty acid composition of plasma lipids before and after consumption of a single dose of emulsified triglyceride based fish oil and triglyceride of similar n-3 compositions in capsule form. The investigators will measure changes in plasma phospholipid, and chylomicron fatty acids.

Conditions

• Healthy Adults

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Coromega Omega-3 Squeeze	660 mg EPA, 434 mg DHA
DIETARY_SUPPLEMENT	Coromega Nectar	660 mg EPA, 436 mg DHA
DIETARY_SUPPLEMENT	Barleans Swirl	660 mg EPA, 660 mg DHA
DIETARY_SUPPLEMENT	Nordic Omega-3 Softgel	660 mg EPA, 440 mg DHA

Timeline

• Start date: 2011-11-01
• Primary completion: 2012-10-01
• Completion: 2016-04-01
• First posted: 2011-12-08
• Last updated: 2018-08-03

Locations

1 site across 1 country: United States